Health
Nanoparticle based shot could boost efficacy, accelerate production of seasonal flu vaccines – BioPharma-Reporter.com
Seasonal flu vaccines typically work 40-60% of the time, according to the US Centers for Disease Control and Prevention (CDC). An experimental recombinant protein…
Key to the vaccine’s success is a liposome the developers created called cobalt-porphyrin-phospholipid, or CoPoP. They are tiny spherical sacs, which are small enough to be considered nanoparticles, and they form the backbone of the vaccine platform.
Described in a study published on May 24 by the Proceedings of the National Academy of Science, the experimental vaccine has reportedly proven effective in preclinical studies.
The results are very encouraging, says the study’s senior author, Jonathan…
-
Business18 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General16 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Business23 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035
-
Noosa News18 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success